Fancalen (lentiviral vector containing the Fanconi anemia-A (FANCA) gene | |
---|---|
Trade Name | |
Orphan Indication | Fanconi Anemia |
USA Market Approval | USA |
USA Designation Date | 2016-05-02 00:00:00 |
Sponsor | Consorcio Centro de Investigaci�n Biom�dica en Red, M.P.;Montforte de Lemos, 3-5 Pabellon 11;Madrid |
Related Access Program
Gerard Vockley, MD, PhD – ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY of
Children’s Hospital of Philadelphia – Bone Marrow Failure Syndrome
Korea University Guro Hospital – Myocardial Infarction
University of California, San Francisco – Bone Marrow Failure
University of Pittsburgh – ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY of
Washington University School of Medicine – Erythrocytosis, Familial, 2
Novartis Pharmaceuticals – Heart Failure With Reduced Ejection Fraction (HF-rEF)
Baylor College of Medicine – Growth Failure
Baylor College of Medicine – Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
Xiaofan Zhu – Fanconi Anemia
Eli Lilly and Company – Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI)
Xiaofan Zhu – Fanconi Anemia